Sponsored Ad | NIKKEI FORUM MELBOURNE 2025 - Leaderboard

Break-even or marginal loss for Biocon Malaysia next year

Break-even or marginal loss for Biocon Malaysia next year

Biocon chairperson and managing director Kiran Mazumdar-Shaw. Photo: Hemant Mishra/Mint

Isha Trivedi

01 February, 2017

Biocon LtdFDAKiran Mazumdar-ShawtrastuzumabUS Food and Drug Administration.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from India

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.